Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity
Clinical trial NCT05444153 · WITHDRAWN
Trial details
- NCT number
- NCT05444153
- Sponsor
- Novo Nordisk A/S
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-06
- Primary completion
- 2024-10-02
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.